Neumora Therapeutics, Inc.
NMRA
$0.44-8.07%
End of day · as of Oct 12, 2026, 8:00 PM ET
Mkt cap
$283.48M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-1.00
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Use this NMRA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NMRA income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company in the Healthcare sector.
Latest cached Neumora Therapeutics, Inc. (NMRA) net income for FY2025 was -$236.9M. Statements: https://lician.com/financials/nmra
Neumora Therapeutics, Inc. (NMRA) market capitalization is $283.5M on the latest cached snapshot.
Neumora Therapeutics, Inc. (NMRA) cached previous close $0.48; day range $0.44 – $0.48; volume 1,209,406. Session quote: https://lician.com/quote/nmra
Neumora Therapeutics, Inc. (NMRA) latest cached earnings event is "NMRA earnings" on Aug 19, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NMRA filing is 8-K · Aug 14, 2026. Filings: https://lician.com/sec/nmra